Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-05-31 4:23 pm Sale | 13G | TURNSTONE BIOLOGICS CORP COM TSBX | Langer Timothy | 993,607 4.300% | -299,613 (-23.17%) | View |
| 2024-04-29 08:22 am Sale | 13G | TURNSTONE BIOLOGICS CORP COM TSBX | FMR LLC | 1,386,323 5.994% | -1,160,338 (-45.56%) | View |
| 2024-03-18 9:13 pm Purchase | 13G | TURNSTONE BIOLOGICS CORP COM TSBX | Langer Timothy | 1,293,220 5.600% | 1,293,220 (New Position) | View |
| 2024-02-09 10:05 am Sale | 13G | TURNSTONE BIOLOGICS CORP COM TSBX | FMR LLC | 2,546,661 11.027% | -372,126 (-12.75%) | View |
| 2023-08-03 4:41 pm Purchase | 13D | TURNSTONE BIOLOGICS CORP COM TSBX | Versant Venture Capital V L.P. | 2,899,216 12.500% | 2,899,216 (New Position) | View |
| 2023-07-27 4:20 pm Purchase | 13G | TURNSTONE BIOLOGICS CORP COM TSBX | Point72 Asset Management L.P. | 1,383,314 6.200% | 1,383,314 (New Position) | View |
| 2023-07-27 08:57 am Purchase | 13G | TURNSTONE BIOLOGICS CORP COM TSBX | FMR LLC | 2,918,787 13.154% | 2,918,787 (New Position) | View |
| 2023-07-24 4:33 pm Purchase | 13D | TURNSTONE BIOLOGICS CORP COM TSBX | ORBIMED ADVISORS LLC | 3,099,265 13.400% | 3,099,265 (New Position) | View |